Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Change in Cash (2016 - 2026)

Tenax Therapeutics' Change in Cash history spans 8 years, with the latest figure at -$159073.0 for Q4 2017.

  • On a quarterly basis, Change in Cash fell 101.72% to -$159073.0 in Q4 2017 year-over-year; TTM through Dec 2017 was -$8.4 million, a 232.45% decrease, with the full-year FY2025 number at $2.7 million, down 96.81% from a year prior.
  • Change in Cash hit -$159073.0 in Q4 2017 for Tenax Therapeutics, up from -$469803.0 in the prior quarter.
  • Over the last five years, Change in Cash for TENX hit a ceiling of $52.0 million in Q2 2014 and a floor of -$36.4 million in Q3 2014.
  • Historically, Change in Cash has averaged $2.3 million across 5 years, with a median of -$576252.5 in 2013.
  • The widest YoY moves for Change in Cash: up 114891.2% in 2014, down 1205.42% in 2014.
  • Tracing TENX's Change in Cash over 5 years: stood at -$1.5 million in 2013, then plummeted by 2276.51% to -$36.4 million in 2014, then surged by 88.27% to -$4.3 million in 2015, then skyrocketed by 317.39% to $9.3 million in 2016, then crashed by 101.72% to -$159073.0 in 2017.
  • Business Quant data shows Change in Cash for TENX at -$159073.0 in Q4 2017, -$469803.0 in Q3 2017, and -$4.8 million in Q2 2017.